APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-lethal Biochemical Weapons

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-lethal Biochemical Weapons Market Outlook and Growth Opportunities 2026

5 January 2026195 pages

Choose your research edition.

Industry ResearchNon-lethal Biochemical Weapons Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-lethal Biochemical Weapons Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Non-lethal Biochemical Weapons Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-lethal Biochemical Weapons Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-lethal Biochemical Weapons Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Non-lethal Biochemical Weapons market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-lethal Biochemical Weapons market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-lethal Biochemical Weapons market include Lamperd Less Lethal, BAE Systems, Inc., QinetiqGroup, Inc., General Dynamics Corporation, TASER International,Inc., Moog, Inc., Raytheon Company, Chemring Group PLC. and Textron Systems, Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-lethal Biochemical Weapons market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-lethal Biochemical Weapons and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-lethal Biochemical Weapons sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-lethal Biochemical Weapons market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-lethal Biochemical Weapons Segment by Company

Lamperd Less Lethal

BAE Systems, Inc.

QinetiqGroup, Inc.

General Dynamics Corporation

TASER International,Inc.

Moog, Inc.

Raytheon Company

Chemring Group PLC.

Textron Systems, Corp

LRAD Corporation

Non-lethal Biochemical Weapons Segment by Type

Directed Energy

Direct Contact

Non-lethal Biochemical Weapons Segment by Application

Military Forces

Law Enforcement Agencies

Non-lethal Biochemical Weapons Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-lethal Biochemical Weapons status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-lethal Biochemical Weapons market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-lethal Biochemical Weapons significant trends, drivers, influence factors in global and regions.

6. To analyze Non-lethal Biochemical Weapons competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-lethal Biochemical Weapons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-lethal Biochemical Weapons and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-lethal Biochemical Weapons.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-lethal Biochemical Weapons market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-lethal Biochemical Weapons industry.

Chapter 3: Detailed analysis of Non-lethal Biochemical Weapons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-lethal Biochemical Weapons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-lethal Biochemical Weapons in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-lethal Biochemical Weapons Industry Trends Table 2. Non-lethal Biochemical Weapons Industry Drivers Table 3. Non-lethal Biochemical Weapons Industry Opportunities and Challenges Table 4. Non-lethal Biochemical Weapons Industry Restraints Table 5. Global Non-lethal Biochemical Weapons Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-lethal Biochemical Weapons Revenue Share by Company (2021-2026) Table 7. Global Non-lethal Biochemical Weapons Sales Volume by Company (k units) & (2021-2026) Table 8. Global Non-lethal Biochemical Weapons Sales Volume Share by Company (2021-2026) Table 9. Global Non-lethal Biochemical Weapons Average Price (USD/unit) of Company (2021-2026) Table 10. Global Non-lethal Biochemical Weapons Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-lethal Biochemical Weapons Key Company Manufacturing Base & Headquarters Table 12. Global Non-lethal Biochemical Weapons Company, Product Type & Application Table 13. Global Non-lethal Biochemical Weapons Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-lethal Biochemical Weapons by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Directed Energy Table 18. Significant Companies of Direct Contact Table 19. Global Non-lethal Biochemical Weapons Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Non-lethal Biochemical Weapons Sales Volume by Type (2021-2026) & (k units) Table 21. Global Non-lethal Biochemical Weapons Sales Volume by Type (2027-2032) & (k units) Table 22. Global Non-lethal Biochemical Weapons Sales Volume Share by Type (2021-2026) Table 23. Global Non-lethal Biochemical Weapons Sales Volume Share by Type (2027-2032) Table 24. Global Non-lethal Biochemical Weapons Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-lethal Biochemical Weapons Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Non-lethal Biochemical Weapons Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Non-lethal Biochemical Weapons Sales Value Share by Type (2021-2026) Table 28. Global Non-lethal Biochemical Weapons Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Military Forces Table 30. Significant Companies of Law Enforcement Agencies Table 31. Global Non-lethal Biochemical Weapons Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Non-lethal Biochemical Weapons Sales Volume by Application (2021-2026) & (k units) Table 33. Global Non-lethal Biochemical Weapons Sales Volume by Application (2027-2032) & (k units) Table 34. Global Non-lethal Biochemical Weapons Sales Volume Share by Application (2021-2026) Table 35. Global Non-lethal Biochemical Weapons Sales Volume Share by Application (2027-2032) Table 36. Global Non-lethal Biochemical Weapons Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Non-lethal Biochemical Weapons Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Non-lethal Biochemical Weapons Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Non-lethal Biochemical Weapons Sales Value Share by Application (2021-2026) Table 40. Global Non-lethal Biochemical Weapons Sales Value Share by Application (2027-2032) Table 41. Global Non-lethal Biochemical Weapons Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Non-lethal Biochemical Weapons Sales by Region (2021-2026) & (k units) Table 43. Global Non-lethal Biochemical Weapons Sales Market Share by Region (2021-2026) Table 44. Global Non-lethal Biochemical Weapons Sales by Region (2027-2032) & (k units) Table 45. Global Non-lethal Biochemical Weapons Sales Market Share by Region (2027-2032) Table 46. Global Non-lethal Biochemical Weapons Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Non-lethal Biochemical Weapons Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Non-lethal Biochemical Weapons Sales Value Share by Region (2021-2026) Table 49. Global Non-lethal Biochemical Weapons Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Non-lethal Biochemical Weapons Sales Value Share by Region (2027-2032) Table 51. Global Non-lethal Biochemical Weapons Market Average Price (USD/unit) by Region (2021-2026) Table 52. Global Non-lethal Biochemical Weapons Market Average Price (USD/unit) by Region (2027-2032) Table 53. Global Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Non-lethal Biochemical Weapons Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 56. Global Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 57. Global Non-lethal Biochemical Weapons Sales by Country (2027-2032) & (k units) Table 58. Global Non-lethal Biochemical Weapons Sales Market Share by Country (2027-2032) Table 59. Global Non-lethal Biochemical Weapons Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Non-lethal Biochemical Weapons Sales Value Market Share by Country (2021-2026) Table 61. Global Non-lethal Biochemical Weapons Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Non-lethal Biochemical Weapons Sales Value Market Share by Country (2027-2032) Table 63. Lamperd Less Lethal Company Information Table 64. Lamperd Less Lethal Business Overview Table 65. Lamperd Less Lethal Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio Table 67. Lamperd Less Lethal Recent Development Table 68. BAE Systems, Inc. Company Information Table 69. BAE Systems, Inc. Business Overview Table 70. BAE Systems, Inc. Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 72. BAE Systems, Inc. Recent Development Table 73. QinetiqGroup, Inc. Company Information Table 74. QinetiqGroup, Inc. Business Overview Table 75. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 77. QinetiqGroup, Inc. Recent Development Table 78. General Dynamics Corporation Company Information Table 79. General Dynamics Corporation Business Overview Table 80. General Dynamics Corporation Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio Table 82. General Dynamics Corporation Recent Development Table 83. TASER International,Inc. Company Information Table 84. TASER International,Inc. Business Overview Table 85. TASER International,Inc. Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio Table 87. TASER International,Inc. Recent Development Table 88. Moog, Inc. Company Information Table 89. Moog, Inc. Business Overview Table 90. Moog, Inc. Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 92. Moog, Inc. Recent Development Table 93. Raytheon Company Company Information Table 94. Raytheon Company Business Overview Table 95. Raytheon Company Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Raytheon Company Non-lethal Biochemical Weapons Product Portfolio Table 97. Raytheon Company Recent Development Table 98. Chemring Group PLC. Company Information Table 99. Chemring Group PLC. Business Overview Table 100. Chemring Group PLC. Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio Table 102. Chemring Group PLC. Recent Development Table 103. Textron Systems, Corp Company Information Table 104. Textron Systems, Corp Business Overview Table 105. Textron Systems, Corp Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio Table 107. Textron Systems, Corp Recent Development Table 108. LRAD Corporation Company Information Table 109. LRAD Corporation Business Overview Table 110. LRAD Corporation Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio Table 112. LRAD Corporation Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Non-lethal Biochemical Weapons Distributors List Table 116. Non-lethal Biochemical Weapons Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Non-lethal Biochemical Weapons Product Image Figure 2. Global Non-lethal Biochemical Weapons Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-lethal Biochemical Weapons Sales (2021-2032) & (k units) Figure 5. Global Non-lethal Biochemical Weapons Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Non-lethal Biochemical Weapons Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Directed Energy Image Figure 10. Direct Contact Image Figure 11. Global Non-lethal Biochemical Weapons Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Non-lethal Biochemical Weapons Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Non-lethal Biochemical Weapons Sales Volume Share by Type (2021-2032) Figure 14. Global Non-lethal Biochemical Weapons Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-lethal Biochemical Weapons Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-lethal Biochemical Weapons Sales Value Share by Type (2021-2032) Figure 17. Military Forces Image Figure 18. Law Enforcement Agencies Image Figure 19. Global Non-lethal Biochemical Weapons Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Non-lethal Biochemical Weapons Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Non-lethal Biochemical Weapons Sales Volume Share by Application (2021-2032) Figure 22. Global Non-lethal Biochemical Weapons Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Non-lethal Biochemical Weapons Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Non-lethal Biochemical Weapons Sales Value Share by Application (2021-2032) Figure 25. Global Non-lethal Biochemical Weapons Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Non-lethal Biochemical Weapons Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Non-lethal Biochemical Weapons Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Non-lethal Biochemical Weapons Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 30. North America Non-lethal Biochemical Weapons Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Non-lethal Biochemical Weapons Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Non-lethal Biochemical Weapons Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 36. South America Non-lethal Biochemical Weapons Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Non-lethal Biochemical Weapons Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Non-lethal Biochemical Weapons Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Non-lethal Biochemical Weapons Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Non-lethal Biochemical Weapons Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Directed Energy
  • Direct Contact
Applications
  • Military Forces
  • Law Enforcement Agencies
Companies covered
  • Lamperd Less Lethal
  • BAE Systems, Inc.
  • QinetiqGroup, Inc.
  • General Dynamics Corporation
  • TASER International,Inc.
  • Moog, Inc.
  • Raytheon Company
  • Chemring Group PLC.
  • Textron Systems, Corp
  • LRAD Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-lethal Biochemical Weapons Sales Value (2021-2032)
  4. 1.2.2 Global Non-lethal Biochemical Weapons Sales Volume (2021-2032)
  5. 1.2.3 Global Non-lethal Biochemical Weapons Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-lethal Biochemical Weapons Market Dynamics
  1. 2.1 Non-lethal Biochemical Weapons Industry Trends
  2. 2.2 Non-lethal Biochemical Weapons Industry Drivers
  3. 2.3 Non-lethal Biochemical Weapons Industry Opportunities and Challenges
  4. 2.4 Non-lethal Biochemical Weapons Industry Restraints
3 Non-lethal Biochemical Weapons Market by Company
  1. 3.1 Global Non-lethal Biochemical Weapons Company Revenue Ranking in 2025
  2. 3.2 Global Non-lethal Biochemical Weapons Revenue by Company (2021-2026)
  3. 3.3 Global Non-lethal Biochemical Weapons Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-lethal Biochemical Weapons Average Price by Company (2021-2026)
  5. 3.5 Global Non-lethal Biochemical Weapons Company Ranking (2024-2026)
  6. 3.6 Global Non-lethal Biochemical Weapons Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-lethal Biochemical Weapons Company Product Type and Application
  8. 3.8 Global Non-lethal Biochemical Weapons Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-lethal Biochemical Weapons Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-lethal Biochemical Weapons Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-lethal Biochemical Weapons Market by Type
  1. 4.1 Non-lethal Biochemical Weapons Type Introduction
  2. 4.1.1 Directed Energy
  3. 4.1.2 Direct Contact
  4. 4.2 Global Non-lethal Biochemical Weapons Sales Volume by Type
  5. 4.2.1 Global Non-lethal Biochemical Weapons Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-lethal Biochemical Weapons Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Non-lethal Biochemical Weapons Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Non-lethal Biochemical Weapons Sales Value by Type
  9. 4.3.1 Global Non-lethal Biochemical Weapons Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-lethal Biochemical Weapons Sales Value by Type (2021-2032)
  11. 4.3.3 Global Non-lethal Biochemical Weapons Sales Value Share by Type (2021-2032)
5 Non-lethal Biochemical Weapons Market by Application
  1. 5.1 Non-lethal Biochemical Weapons Application Introduction
  2. 5.1.1 Military Forces
  3. 5.1.2 Law Enforcement Agencies
  4. 5.2 Global Non-lethal Biochemical Weapons Sales Volume by Application
  5. 5.2.1 Global Non-lethal Biochemical Weapons Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-lethal Biochemical Weapons Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non-lethal Biochemical Weapons Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non-lethal Biochemical Weapons Sales Value by Application
  9. 5.3.1 Global Non-lethal Biochemical Weapons Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-lethal Biochemical Weapons Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non-lethal Biochemical Weapons Sales Value Share by Application (2021-2032)
6 Non-lethal Biochemical Weapons Regional Sales and Value Analysis
  1. 6.1 Global Non-lethal Biochemical Weapons Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-lethal Biochemical Weapons Sales by Region (2021-2032)
  3. 6.2.1 Global Non-lethal Biochemical Weapons Sales by Region: 2021-2026
  4. 6.2.2 Global Non-lethal Biochemical Weapons Sales by Region (2027-2032)
  5. 6.3 Global Non-lethal Biochemical Weapons Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-lethal Biochemical Weapons Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-lethal Biochemical Weapons Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-lethal Biochemical Weapons Sales Value by Region (2027-2032)
  9. 6.5 Global Non-lethal Biochemical Weapons Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-lethal Biochemical Weapons Sales Value (2021-2032)
  12. 6.6.2 North America Non-lethal Biochemical Weapons Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-lethal Biochemical Weapons Sales Value (2021-2032)
  15. 6.7.2 Europe Non-lethal Biochemical Weapons Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-lethal Biochemical Weapons Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-lethal Biochemical Weapons Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-lethal Biochemical Weapons Sales Value (2021-2032)
  21. 6.9.2 South America Non-lethal Biochemical Weapons Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-lethal Biochemical Weapons Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-lethal Biochemical Weapons Sales Value Share by Country, 2025 VS 2032
7 Non-lethal Biochemical Weapons Country-level Sales and Value Analysis
  1. 7.1 Global Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-lethal Biochemical Weapons Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-lethal Biochemical Weapons Sales by Country (2021-2032)
  4. 7.3.1 Global Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  5. 7.3.2 Global Non-lethal Biochemical Weapons Sales by Country (2027-2032)
  6. 7.4 Global Non-lethal Biochemical Weapons Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-lethal Biochemical Weapons Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-lethal Biochemical Weapons Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-lethal Biochemical Weapons Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-lethal Biochemical Weapons Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-lethal Biochemical Weapons Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lamperd Less Lethal
  2. 8.1.1 Lamperd Less Lethal Company Information
  3. 8.1.2 Lamperd Less Lethal Business Overview
  4. 8.1.3 Lamperd Less Lethal Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio
  6. 8.1.5 Lamperd Less Lethal Recent Developments
  7. 8.2 BAE Systems, Inc.
  8. 8.2.1 BAE Systems, Inc. Company Information
  9. 8.2.2 BAE Systems, Inc. Business Overview
  10. 8.2.3 BAE Systems, Inc. Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio
  12. 8.2.5 BAE Systems, Inc. Recent Developments
  13. 8.3 QinetiqGroup, Inc.
  14. 8.3.1 QinetiqGroup, Inc. Company Information
  15. 8.3.2 QinetiqGroup, Inc. Business Overview
  16. 8.3.3 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio
  18. 8.3.5 QinetiqGroup, Inc. Recent Developments
  19. 8.4 General Dynamics Corporation
  20. 8.4.1 General Dynamics Corporation Company Information
  21. 8.4.2 General Dynamics Corporation Business Overview
  22. 8.4.3 General Dynamics Corporation Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio
  24. 8.4.5 General Dynamics Corporation Recent Developments
  25. 8.5 TASER International,Inc.
  26. 8.5.1 TASER International,Inc. Company Information
  27. 8.5.2 TASER International,Inc. Business Overview
  28. 8.5.3 TASER International,Inc. Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio
  30. 8.5.5 TASER International,Inc. Recent Developments
  31. 8.6 Moog, Inc.
  32. 8.6.1 Moog, Inc. Company Information
  33. 8.6.2 Moog, Inc. Business Overview
  34. 8.6.3 Moog, Inc. Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio
  36. 8.6.5 Moog, Inc. Recent Developments
  37. 8.7 Raytheon Company
  38. 8.7.1 Raytheon Company Company Information
  39. 8.7.2 Raytheon Company Business Overview
  40. 8.7.3 Raytheon Company Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Raytheon Company Non-lethal Biochemical Weapons Product Portfolio
  42. 8.7.5 Raytheon Company Recent Developments
  43. 8.8 Chemring Group PLC.
  44. 8.8.1 Chemring Group PLC. Company Information
  45. 8.8.2 Chemring Group PLC. Business Overview
  46. 8.8.3 Chemring Group PLC. Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio
  48. 8.8.5 Chemring Group PLC. Recent Developments
  49. 8.9 Textron Systems, Corp
  50. 8.9.1 Textron Systems, Corp Company Information
  51. 8.9.2 Textron Systems, Corp Business Overview
  52. 8.9.3 Textron Systems, Corp Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio
  54. 8.9.5 Textron Systems, Corp Recent Developments
  55. 8.10 LRAD Corporation
  56. 8.10.1 LRAD Corporation Company Information
  57. 8.10.2 LRAD Corporation Business Overview
  58. 8.10.3 LRAD Corporation Non-lethal Biochemical Weapons Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio
  60. 8.10.5 LRAD Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-lethal Biochemical Weapons Value Chain Analysis
  2. 9.1.1 Non-lethal Biochemical Weapons Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-lethal Biochemical Weapons Sales Mode & Process
  6. 9.2 Non-lethal Biochemical Weapons Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-lethal Biochemical Weapons Distributors
  9. 9.2.3 Non-lethal Biochemical Weapons Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst